What is TurnCare?
TurnCare, Inc. operates at the intersection of clinical therapy and patient safety, providing the Guardian system to healthcare facilities. The platform is engineered to adapt to individual patient needs in real time, specifically targeting the reduction of adverse events and the shortening of hospital stays. By addressing complex physiological challenges such as vascular compression and tissue ischemia, TurnCare facilitates early mobility, which is essential for preventing the rapid decline of physical function in hospitalized patients. The company's market position is defined by its commitment to evidence-based outcomes and the integration of adaptive technology into standard hospital workflows.
How much funding has TurnCare raised?
TurnCare has raised a total of $3.5M across 2 funding rounds:
Private Equity
$3.4M
Debt
$150K
Private Equity (2017): $3.4M, investors not publicly disclosed
Debt (2020): $150K led by PPP
Key Investors in TurnCare
PPP
Public-Private Partnership
Undisclosed Investor
An institutional backer participating in the company's private equity funding round to support long-term development.
Undisclosed Investor
A strategic partner providing capital to facilitate the scaling of innovative medical technology solutions.
What's next for TurnCare?
With this major strategic investment, TurnCare is poised to expand its footprint within the enterprise healthcare market. The company is expected to prioritize the scaling of its Guardian platform, focusing on broader clinical adoption and the refinement of its real-time therapy algorithms. Future growth will likely center on deepening its data analytics capabilities to provide more granular insights into patient recovery trajectories. As the healthcare industry continues to emphasize value-based care, TurnCare is well-positioned to capitalize on the demand for solutions that simultaneously improve patient outcomes and reduce the operational costs associated with prolonged hospitalizations.
See full TurnCare company page
